ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,145Medicare Part D Prescriptions Filled, Including Refills

Rank: 66 out of 198

$451K Total Retail Price of All Prescriptions

Rank: 73 out of 198

384 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 384 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 384 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 7,665 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
SIMVASTATIN 462 407 1 2
AMLODIPINE BESYLATE 343 320 2 4
OMEPRAZOLE 318 263 3 3
FUROSEMIDE 304 272 4 5
WARFARIN SODIUM 289 274 5 7
LEVOTHYROXINE SODIUM 251 233 6 1
HYDROCODONE-ACETAMINOPHEN 235 139 S3 7 8
POTASSIUM CHLORIDE 231 222 8 9
MELOXICAM 229 200 9 30
HYDROCHLOROTHIAZIDE 225 193 10 16
TRAMADOL HCL 183 133 11 15
GABAPENTIN 176 133 12 14
LISINOPRIL 167 155 13 6
METOPROLOL TARTRATE 155 141 14 10
CITALOPRAM HBR 152 143 15 20
ATENOLOL 136 133 16 17
ZOLPIDEM TARTRATE 126 83 17 22
METFORMIN HCL 125 113 18 13
TAMSULOSIN HCL 118 102 19 27
OXYCODONE-ACETAMINOPHEN 117 113 S2 20 79
FOSINOPRIL SODIUM 111 96 21 156
CARVEDILOL 104 99 22 24
SERTRALINE HCL 103 84 23 25
LOSARTAN POTASSIUM 102 98 24 18
NEXIUM 94 45 25 40
DONEPEZIL HCL 88 87 26 28
PANTOPRAZOLE SODIUM 82 76 27 31
ATORVASTATIN CALCIUM 79 67 28 12
CYCLOBENZAPRINE HCL 78 60 R 29 67
ESCITALOPRAM OXALATE 74 55 30 53
METOPROLOL SUCCINATE 73 69 31 11
CLOPIDOGREL 60 60 32 42
ADVAIR DISKUS 58 34 33 47
ALENDRONATE SODIUM 56 56 34 21
CIPROFLOXACIN HCL 54 49 35 55
FLUTICASONE PROPIONATE 54 45 35 39
OXYCODONE HCL 50 0 S2 37 112
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 20, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.